15 min listen
Dual Antiplatelet Therapy After Acute Coronary Syndrome
Dual Antiplatelet Therapy After Acute Coronary Syndrome
ratings:
Length:
24 minutes
Released:
Apr 20, 2021
Format:
Podcast episode
Description
Dual antiplatelet therapy, typically aspirin and an oral P2Y12 receptor inhibitor (clopidogrel, prasugrel, ticagrelor, cangrelor), reduces adverse events after acute coronary syndrome (ACS) but choice of agent and optimal duration may be patient-specific. Umair Khalid, MD, a cardiologist at the Baylor School of Medicine in Houston, discusses how to use these agents in management of ACS. Related Article(s): Oral Antiplatelet Therapy After Acute Coronary Syndrome
Released:
Apr 20, 2021
Format:
Podcast episode
Titles in the series (100)
Using Likelihood Ratios to Understand How Chest Pain Predicts Acute Coronary Syndrome: Interview with David Simel, MD, author of by JAMA Clinical Reviews